AbbVie (NYSE: ABBV)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
AbbVie Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
Why AbbVie Stock Fell Today
AbbVie stock fell despite beating third-quarter expectations and raising its full-year outlook. Here's what investors need to know.
Dividend Kings of 2023
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
The market has punished them, but don't overlook these stocks.
9 Best Index Funds to Invest In for the Long Term
Here are the nine best index funds to add to your portfolio for steady, low-cost growth.
Is AbbVie Stock Too Pricey to Touch Right Now?
Other pharmaceutical companies are trading for far lower multiples.
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
These three top-notch stocks would make great additions to any dividend portfolio.
What Is a Patent Cliff?
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October
These two healthcare stocks are reliable passive income vehicles.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q3 2023 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2023.
AbbVie (ABBV) Q2 2023 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2023.
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2023.
AbbVie (ABBV) Q4 2022 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.